Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
07 2022
Historique:
received: 11 02 2022
revised: 12 04 2022
accepted: 25 04 2022
pubmed: 15 5 2022
medline: 15 6 2022
entrez: 14 5 2022
Statut: ppublish

Résumé

Salvage total glossectomy (TG) or total glosso-laryngectomy (TGL) remain controversial, as highly morbid procedures. The objective was to describe oncological and functional outcomes after salvage TG or TGL. We performed a multicenter retrospective study, including patients with previous neck irradiation undergoing TG or TGL for squamous cell carcinoma involving the base of tongue. We included 42 patients: 27 in the TG group and 15 in the TGL group. For the entire cohort, median OS and DFS were estimated at 19 months (95% IC [14-44]) and 10 months (95% IC [7-13]) respectively, with no difference between the two groups. After a median follow-up of 90 months, 10 patients (24%) were alive and free of disease. Att he end of follow-up, we noted a gastrostomy dependency of 89% and 87 %respectively in the TG and TGL group, and 48% of patients in the TG group had a tracheotomy. Although local control is difficult to achieve after salvage TG or TGL, these procedures are associated with acceptable survival and chance of cure for a last-resort situation. TG and TGL can be proposed in selected motivated patients after careful shared decision-making.

Sections du résumé

BACKGROUND
Salvage total glossectomy (TG) or total glosso-laryngectomy (TGL) remain controversial, as highly morbid procedures. The objective was to describe oncological and functional outcomes after salvage TG or TGL.
METHODS
We performed a multicenter retrospective study, including patients with previous neck irradiation undergoing TG or TGL for squamous cell carcinoma involving the base of tongue.
RESULTS
We included 42 patients: 27 in the TG group and 15 in the TGL group. For the entire cohort, median OS and DFS were estimated at 19 months (95% IC [14-44]) and 10 months (95% IC [7-13]) respectively, with no difference between the two groups. After a median follow-up of 90 months, 10 patients (24%) were alive and free of disease. Att he end of follow-up, we noted a gastrostomy dependency of 89% and 87 %respectively in the TG and TGL group, and 48% of patients in the TG group had a tracheotomy.
CONCLUSION
Although local control is difficult to achieve after salvage TG or TGL, these procedures are associated with acceptable survival and chance of cure for a last-resort situation. TG and TGL can be proposed in selected motivated patients after careful shared decision-making.

Identifiants

pubmed: 35567979
pii: S1368-8375(22)00185-3
doi: 10.1016/j.oraloncology.2022.105896
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

105896

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Auteurs

Paul Mazerolle (P)

Department of Surgery, University Cancer Institute Toulouse - Oncopole, University Hospital of Toulouse, Toulouse, France.

Carine Fuchsmann (C)

Department of Otolaryngology-Head Neck Surgery, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France.

Philippe Schultz (P)

Department of Otorhinolaryngology, Centre Hospitalo-Universitaire de Hautepierre, Strasbourg, France.

Nadia Benmoussa (N)

Department of Head and Neck Surgical Oncology, Gustave Roussy, Paris-Saclay University, Villejuif, 94805, France.

Olivier Malard (O)

Department of Head and Neck Surgery, University Hospital of Nantes, France.

Alexandre Bozec (A)

Department of Head and Neck Surgery, Institut Universitaire de la Face et du Cou, Nice, France.

Sophie Deneuve (S)

Department of Oncologic Surgery, Léon Bérard Center, Lyon, France.

Mireille Folia (M)

Department of Otolaryngology-Head and Neck Surgery, François-Mitterrand University Hospital Center, Dijon, France.

Marion Perréard (M)

Department of Head and Neck Surgery, University Hospital of Caen, France.

Audrey Lasne-Cardon (A)

Department of Head and Neck Surgery, François Baclesse Cancer Center, Caen, France.

Emilien Chabrillac (E)

Department of Surgery, University Cancer Institute Toulouse - Oncopole, University Hospital of Toulouse, Toulouse, France.

Sébastien Vergez (S)

Department of Surgery, University Cancer Institute Toulouse - Oncopole, University Hospital of Toulouse, Toulouse, France.

Léonor Chaltiel (L)

Biostatistics Unit, Institut Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole Toulouse, France.

Agnès Dupret-Bories (A)

Department of Surgery, University Cancer Institute Toulouse - Oncopole, University Hospital of Toulouse, Toulouse, France. Electronic address: Dupret-Bories.Agnes@iuct-oncopole.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH